Welcome to our dedicated page for Sonendo news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on Sonendo stock.
Sonendo, Inc. reports developments as a commercial-stage dental technology company built around the GentleWave® System for root canal therapy. The company develops and manufactures a platform that uses procedure fluid optimization, broad-spectrum acoustic energy and fluid dynamics to clean and disinfect microscopic spaces within teeth while preserving tooth structure.
SONX news commonly covers quarterly and annual results, console sales, procedure-related consumables and service revenue, gross margin, operating expense reductions and cash-flow guidance. Company updates also address commercial execution, liquidity actions such as private placements and credit facility amendments, leadership changes, and the completed divestiture of the TDO practice management software segment.
Sonendo, Inc. (NYSE: SONX) announced the upcoming departures of Jacqueline Collins, General Counsel, and Mehrzad Khakpour, Chief Technology Officer, both effective July 2022. Collins played a key role in developing the legal framework that facilitated the company's IPO in 2021, while Khakpour contributed to its early research and technology initiatives. The company is currently seeking new leaders to guide its R&D efforts. Despite these changes, Sonendo continues to grow, with over 800,000 GentleWave procedures performed, showcasing the technology's adoption.
On May 24, 2022, Sonendo (NYSE: SONX) appointed Crowe PR as its agency of record to enhance brand visibility through a multi-channel communications program. Crowe PR will support Sonendo's strategic communications for its GentleWave® System, which offers a less invasive alternative to traditional root canal therapy. Since its public debut in October 2021, Sonendo has performed over 800,000 GentleWave procedures, reflecting its growth in the dental technology sector. Executives emphasize a goal to increase awareness among endodontists and consumers.
Sonendo, Inc. (NYSE: SONX), a leader in dental technology, will participate in the Stifel Jaws and Paws Conference on June 1 at 8:35 a.m. ET. President & CEO Bjarne Bergheim and CFO Michael Watts will present during the event. The presentation will be accessible via an audio webcast on the company’s website at www.sonendo.com.
Sonendo develops the GentleWave® System, which revolutionizes root canal therapy by cleaning and disinfecting teeth without invasive procedures, leading to improved clinical outcomes and economics for dental practices.
Sonendo reported a 22% increase in total revenue for Q1 2022, reaching $9.0 million, driven by higher GentleWave console and procedure instrument sales.
Gross margin improved to 25% from 23% year-over-year, despite supply chain disruptions. However, operating expenses grew significantly, leading to a net loss of $15.5 million, up from $10.9 million in Q1 2021. The company maintains its full-year revenue guidance of $40 million to $43 million.
Sonendo (NYSE: SONX) is participating in the American Association of Endodontists’ Annual Meeting from April 27-30, 2022, in Phoenix, AZ. The event marks the first in-person meeting since 2019, expecting over 3,000 industry professionals. Sonendo will showcase its new CleanFlow procedure instrument designed for a less invasive root canal experience. Attendees can engage in hands-on demonstrations of the GentleWave System and attend lectures from key opinion leaders. Sonendo aims to enhance adoption of its technology and network with peers.
Sonendo, Inc. (NYSE: SONX) has launched the CleanFlow™ procedure instrument for its GentleWave® System, aimed at enhancing root canal therapy. This new technology simplifies workflow, minimizes steps for practitioners, and significantly improves patient experience, with 99.5% of patients reporting no pain during the procedure. With over 800,000 GentleWave procedures completed, Sonendo demonstrates strong market adoption and commitment to innovation in dental technology.
Sonendo, Inc. (NYSE: SONX) will announce its financial results for Q1 2022 on May 10, 2022, after market close. A conference call will follow at 1:30 PM PT. Interested investors can listen via phone or through a live webcast on the company’s website. Sonendo is recognized for its GentleWave® System, aimed at treating tooth decay more efficiently while preserving tooth structure. The company will also participate in the Bank of America Healthcare Conference on May 11, 2022, featuring a fireside chat at 10:40 AM PT.
Sonendo, Inc. (NYSE: SONX) has launched the GentleWave Community app, aimed at enhancing endodontic practices. This industry-first application enables GentleWave providers to exchange clinical insights and treatment tips in a private forum. The app is accessible on both iOS and Android platforms, offering features like push notifications and real-time engagement. This initiative is part of Sonendo's commitment to support the specialty of endodontics and improve doctor and patient experiences. It complements existing digital tools such as TDO, Sonendo's practice management software.
Sonendo, a dental technology company traded as NYSE:SONX, is set to present at the Piper Sandler Dental Day on March 29 at 12:00 p.m. ET. CEO Bjarne Bergheim and CFO Michael Watts will discuss the GentleWave® System, which treats tooth decay with minimal invasiveness. This innovative system improves clinical outcomes significantly compared to traditional methods, leading to rapid healing and reduced post-operative pain. Additionally, Sonendo owns TDO® Software, enhancing dental practice management.
Sonendo, a leading dental technology company, reported its financial results for Q4 and the full year 2021. Total revenue for Q4 reached $9.9 million, a 14% increase year-over-year, and $33.2 million for the entire year, marking a 42% growth from 2020. The company achieved a gross margin of 25% in Q4, up from 20% in Q4 2020. Despite a net loss of $13.7 million in Q4, the company raised $84 million during its IPO. For 2022, Sonendo expects to generate between $40 million and $43 million in revenue.